Research Topics
| Zengjian HuSummaryAffiliation: Howard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
WinDock: structure-based drug discovery on Windows-based PCsZengjian Hu
Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, District of Columbia 20059, USA
J Comput Chem 28:2347-51. 2007..WinDock is coded in C++...
Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approachZengjian Hu
Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, DC 20059, USA
Ethn Dis 20:S1-45-9. 2010..Our study will be of help to design new pharmaceuticals for the treatment of AIDS...
Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang PowderJack Z Hu
Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, DC 20059, USA
Interdiscip Sci 2:151-6. 2010..Our study will be of help to identify the pharmacophores of inhibitors binding to HIV-1 integrase and design new pharmaceuticals for the treatment of AIDS...
Ligand binding and circular permutation modify residue interaction network in DHFRZengjian Hu
Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Washington, District of Columbia, United States of America
PLoS Comput Biol 3:e117. 2007..Ligand binding at the active site has profound effects on the network centrality, especially the closeness...
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approachJudith Varady
Departments of Internal Medicine and Medicinal Chemistry, University of Michigan, 3-316 CCGC Box 0934, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0934, USA
J Med Chem 46:4377-92. 2003..Furthermore, the employed hybrid approach may be more effective for lead discovery from a large chemical database than either pharmacophore-based or structure-based database screening alone...
